Sampre Nutritions Limited, a prominent player in the FMCG sector, has taken a significant step towards international expansion by approving the issuance of Foreign Currency Convertible Bonds (FCCBs) worth USD 40 million. This move is part of a larger USD 100 million FCCB program aimed at strengthening the company's global presence, particularly in high-growth regions such as Egypt and Liberia.

FCCB Issuance Details

The Board of Directors of Sampre Nutritions Limited has approved the issuance of 400 FCCBs, each with a par value of USD 100,000. The bonds will be offered at a 15% discount, with an offering price of USD 85,000 per bond. Key features of the FCCB issuance include:

Conversion and Utilization of Funds

The FCCBs can be converted to equity shares at the bondholders' discretion, with the following conditions:

• Conversion window: Any time after one week from issuance until maturity
• Conversion price: To be determined as per SEBI guidelines

The funds raised through this FCCB issuance will be primarily utilized for Sampre Nutritions' global expansion strategy, focusing on:

1. Establishing a presence in Egypt
2. Expanding operations in Liberia (Monrovia)

These strategic moves are designed to strengthen the company's foothold in high-growth regions, diversify revenue streams, and capitalize on emerging opportunities in the international FMCG sectors.

Strategic Decisions and Future Outlook

In light of this FCCB issuance, Sampre Nutritions has made some notable decisions:

1. Postponement of Preferential Allotment: The company has decided to postpone a previously planned preferential allotment of securities.

2. Focus on International Markets: By targeting Egypt and Liberia, Sampre Nutritions aims to broaden its global footprint and tap into new market opportunities.

3. Long-term Growth Strategy: This move aligns with the company's vision to strengthen its presence in high-growth regions and diversify its revenue streams in the international FMCG sector.

The Board meeting that approved these decisions was held on October 3, 2025, commencing at 2:00 P.M. (IST) and concluding at 5:00 P.M. (IST).

Sampre Nutritions Limited's strategic decision to issue FCCBs and expand globally reflects the company's ambition to capitalize on international growth opportunities and enhance its position in the competitive FMCG market. As the company embarks on this new phase of expansion, investors and industry observers will be keenly watching the impact of these moves on Sampre Nutritions' future growth and market position.

Sampre Nutritions Limited , a company listed on the BSE, has unveiled a series of strategic moves aimed at enhancing shareholder value and improving stock liquidity. The company's board of directors has approved several key resolutions, which will be put to shareholders for approval through a postal ballot.

Share Split to Enhance Liquidity

In a bid to make its shares more accessible to small investors and boost liquidity, Sampre Nutritions has proposed a 1:2 share split. If approved, each existing equity share with a face value of INR 10.00 will be sub-divided into two equity shares with a face value of INR 5.00 each.

Bonus Share Issue to Reward Shareholders

Following the share split, the company plans to issue bonus shares in a 1:1 ratio. This means shareholders will receive one new equity share for every share held, effectively doubling their shareholding. The bonus issue will be funded by capitalizing up to INR 21.85 crore from the company's securities premium account.

Expansion of Authorized Share Capital

To facilitate these corporate actions, Sampre Nutritions has proposed increasing its authorized share capital from INR 35.00 crore to INR 100.00 crore. This expansion will create room for the issuance of additional shares and provide flexibility for future capital raising activities.

Key Details of the Proposal

Voting Process and Timeline

The company has initiated a postal ballot process for shareholder approval. Key dates for the e-voting process are as follows:

• Cut-off Date: September 19, 2025
• E-voting Start: September 27, 2025 (9:00 AM IST)
• E-voting End: October 26, 2025 (5:00 PM IST)

Management's Perspective

The board of Sampre Nutritions believes these measures will enhance share liquidity and make the company's shares more affordable for small investors. The bonus issue is seen as a way to reward shareholders for their continued support and loyalty.

Regulatory Compliance

The company has emphasized that the new bonus shares will be issued in dematerialized form only, in compliance with SEBI regulations. For shareholders holding physical shares, the bonus shares will be credited to a separate suspense escrow demat account until they are converted to dematerialized form.

Sampre Nutritions Limited has stated that these corporate actions will not result in any change to the company's shareholding pattern. The proposed resolutions are subject to shareholder approval and other necessary regulatory clearances.

Investors and shareholders are advised to review the detailed postal ballot notice for complete information on the proposed resolutions and voting procedures.